NEWER BETA-BLOCKERS AND THE TREATMENT OF HYPERTENSION

被引：13

作者：

MCAREAVEY, D

VERMEULEN, R

ROBERTSON, JIS

机构：

[1] Department of Cardiology, Royal Infirmary, Edinburgh

[2] Janssen Research Foundation, Beerse

[3] Department of Medicine, Prince of Wales Hospital, Chinese University of Hong Kong

来源：

CARDIOVASCULAR DRUGS AND THERAPY | 1991年 / 5卷 / 03期

关键词：

ARTERIAL COMPLIANCE; BLOOD LIPIDS; CARDIAC HYPERTROPHY; CARDIAC OUTPUT; QUALITY OF LIFE;

D O I：

10.1007/BF03029727

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Beta-adrenoceptor blocking agents are established as one of the principal classes of antihypertensive agents. Despite progressive refinements over the years, they still possess some unwanted effects, which limit their considerable value. In recent years a wide range of variations upon the beta-blocker theme has been developed. The full clinical advantages of the newer agents remain to be defined.

引用

页码：577 / 587

页数：11

共 118 条

[1]

Prichard B.N.C., Hyportensive action of pronethalol, Br Med J, 1, pp. 1227-1228, (1964)

[2]

Prichard B.N.C., Gillman P., Use of propranolol in treatment of hypertension, Br Med J, 2, pp. 725-727, (1964)

[3]

Robertson J.I.S., State of the art review: Beta-blockade and the treatment of hypertension, Drugs, 25, 2, pp. 5-11, (1983)

[4]

Cruickshank J.M., Prichard B.N.C., Beta-blockers in clinical practice, (1987)

[5]

Conway J., Hypotensive mechanisms of beta-blockers, Eur Heart J, 4, 500, pp. 43-51, (1983)

[6]

Main in't Velt A.J.C., Schalekamp M.A.D.H., How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their anti-hypertensive mechanism, Br J Clin Pharmacol, 13, pp. 245S-257S, (1982)

[7]

Chinn R.H., Dusterdieck G., The response of blood pressure to infusion of angiotensin II: Relation to plasma concentrations of renin and angiotensin II, Clin Sci, 42, pp. 489-504, (1972)

[8]

Hollifield J.W., Sherman K., Vander Zwaag R., Shand D.G., Proposed mechanisms of propranolol’s antihypertensive effect in essential hypertension, N Engl J Med, 295, 2, pp. 68-73, (1976)

[9]

Anavekar S.N., Louis W.J., Morgan T.O., Et al., The relationship of plasma levels of pindolol in hypertensive patients to effect on blood pressure, plasma renin and plasma noradrenaline levels, Clin Exp Pharmacol Physiol, 2, pp. 203-212, (1975)

[10]

Sonkodi S., Agabiti-Rosei F., Fraser R., Et al., Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: Effect of prior metoprolol and propranolol, Br J Clin Pharmacol, 13, pp. 341-350, (1982)

← 1 2 3 4 5 6 7 8 9 10 →